United States Viral-Vectored Vaccines Market Report 2016

September 2016 | 123 pages | ID: UCFDF9603EBEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Viral-Vectored Vaccines

Revenue, means the sales value of Viral-Vectored Vaccines

This report studies sales (consumption) of Viral-Vectored Vaccines in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Bayer HealthCare AG (Germany)
• Biogenesis-Bago (Argentina)
• Boehringer Ingelheim GmbH (Germany)
• Ceva Sante Animale (France)
• Heska Corporation (US)
• Indian Immunologicals Ltd (India)
• Lohmann Animal Health (US)
• Merck Animal Health (US)
• Merial Ltd. (US)
• Protein Sciences Corporation (US)
• Virbac SA (France)
• Zoetis Inc. (US)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Viral-Vectored Vaccines in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Viral-Vectored Vaccines Market Report 2016

1 VIRAL-VECTORED VACCINES OVERVIEW

1.1 Product Overview and Scope of Viral-Vectored Vaccines
1.2 Classification of Viral-Vectored Vaccines
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Viral-Vectored Vaccines
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Viral-Vectored Vaccines (2011-2021)
  1.4.1 USA Viral-Vectored Vaccines Sales and Growth Rate (2011-2021)
  1.4.2 USA Viral-Vectored Vaccines Revenue and Growth Rate (2011-2021)

2 USA VIRAL-VECTORED VACCINES COMPETITION BY MANUFACTURERS

2.1 USA Viral-Vectored Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Viral-Vectored Vaccines Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Viral-Vectored Vaccines Average Price by Manufactures (2015 and 2016)
2.4 Viral-Vectored Vaccines Market Competitive Situation and Trends
  2.4.1 Viral-Vectored Vaccines Market Concentration Rate
  2.4.2 Viral-Vectored Vaccines Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 USA VIRAL-VECTORED VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 USA Viral-Vectored Vaccines Sales and Market Share by Type (2011-2016)
3.2 USA Viral-Vectored Vaccines Revenue and Market Share by Type (2011-2016)
3.3 USA Viral-Vectored Vaccines Price by Type (2011-2016)
3.4 USA Viral-Vectored Vaccines Sales Growth Rate by Type (2011-2016)

4 USA VIRAL-VECTORED VACCINES SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 USA Viral-Vectored Vaccines Sales and Market Share by Application (2011-2016)
4.2 USA Viral-Vectored Vaccines Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 USA VIRAL-VECTORED VACCINES MANUFACTURERS PROFILES/ANALYSIS

5.1 Bayer HealthCare AG (Germany)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Viral-Vectored Vaccines Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Bayer HealthCare AG (Germany) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Biogenesis-Bago (Argentina)
  5.2.2 Viral-Vectored Vaccines Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Biogenesis-Bago (Argentina) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Boehringer Ingelheim GmbH (Germany)
  5.3.2 Viral-Vectored Vaccines Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Boehringer Ingelheim GmbH (Germany) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Ceva Sante Animale (France)
  5.4.2 Viral-Vectored Vaccines Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Ceva Sante Animale (France) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Heska Corporation (US)
  5.5.2 Viral-Vectored Vaccines Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Heska Corporation (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Indian Immunologicals Ltd (India)
  5.6.2 Viral-Vectored Vaccines Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Indian Immunologicals Ltd (India) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Lohmann Animal Health (US)
  5.7.2 Viral-Vectored Vaccines Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Lohmann Animal Health (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Merck Animal Health (US)
  5.8.2 Viral-Vectored Vaccines Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Merck Animal Health (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Merial Ltd. (US)
  5.9.2 Viral-Vectored Vaccines Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Merial Ltd. (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Protein Sciences Corporation (US)
  5.10.2 Viral-Vectored Vaccines Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Protein Sciences Corporation (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Virbac SA (France)
5.12 Zoetis Inc. (US)

6 VIRAL-VECTORED VACCINES MANUFACTURING COST ANALYSIS

6.1 Viral-Vectored Vaccines Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Viral-Vectored Vaccines

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Viral-Vectored Vaccines Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Viral-Vectored Vaccines Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 USA VIRAL-VECTORED VACCINES MARKET FORECAST (2016-2021)

10.1 USA Viral-Vectored Vaccines Sales, Revenue Forecast (2016-2021)
10.2 USA Viral-Vectored Vaccines Sales Forecast by Type (2016-2021)
10.3 USA Viral-Vectored Vaccines Sales Forecast by Application (2016-2021)
10.4 Viral-Vectored Vaccines Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Viral-Vectored Vaccines
Table Classification of Viral-Vectored Vaccines
Figure USA Sales Market Share of Viral-Vectored Vaccines by Type in 2015
Table Application of Viral-Vectored Vaccines
Figure USA Sales Market Share of Viral-Vectored Vaccines by Application in 2015
Figure USA Viral-Vectored Vaccines Sales and Growth Rate (2011-2021)
Figure USA Viral-Vectored Vaccines Revenue and Growth Rate (2011-2021)
Table USA Viral-Vectored Vaccines Sales of Key Manufacturers (2015 and 2016)
Table USA Viral-Vectored Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Viral-Vectored Vaccines Sales Share by Manufacturers
Figure 2016 Viral-Vectored Vaccines Sales Share by Manufacturers
Table USA Viral-Vectored Vaccines Revenue by Manufacturers (2015 and 2016)
Table USA Viral-Vectored Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Viral-Vectored Vaccines Revenue Share by Manufacturers
Table 2016 USA Viral-Vectored Vaccines Revenue Share by Manufacturers
Table USA Market Viral-Vectored Vaccines Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Viral-Vectored Vaccines Average Price of Key Manufacturers in 2015
Figure Viral-Vectored Vaccines Market Share of Top 3 Manufacturers
Figure Viral-Vectored Vaccines Market Share of Top 5 Manufacturers
Table USA Viral-Vectored Vaccines Sales by Type (2011-2016)
Table USA Viral-Vectored Vaccines Sales Share by Type (2011-2016)
Figure USA Viral-Vectored Vaccines Sales Market Share by Type in 2015
Table USA Viral-Vectored Vaccines Revenue and Market Share by Type (2011-2016)
Table USA Viral-Vectored Vaccines Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Viral-Vectored Vaccines by Type (2011-2016)
Table USA Viral-Vectored Vaccines Price by Type (2011-2016)
Figure USA Viral-Vectored Vaccines Sales Growth Rate by Type (2011-2016)
Table USA Viral-Vectored Vaccines Sales by Application (2011-2016)
Table USA Viral-Vectored Vaccines Sales Market Share by Application (2011-2016)
Figure USA Viral-Vectored Vaccines Sales Market Share by Application in 2015
Table USA Viral-Vectored Vaccines Sales Growth Rate by Application (2011-2016)
Figure USA Viral-Vectored Vaccines Sales Growth Rate by Application (2011-2016)
Table Bayer HealthCare AG (Germany) Basic Information List
Table Bayer HealthCare AG (Germany) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer HealthCare AG (Germany) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Biogenesis-Bago (Argentina) Basic Information List
Table Biogenesis-Bago (Argentina) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biogenesis-Bago (Argentina) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Boehringer Ingelheim GmbH (Germany) Basic Information List
Table Boehringer Ingelheim GmbH (Germany) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim GmbH (Germany) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Ceva Sante Animale (France) Basic Information List
Table Ceva Sante Animale (France) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ceva Sante Animale (France) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Heska Corporation (US) Basic Information List
Table Heska Corporation (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Heska Corporation (US) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Indian Immunologicals Ltd (India) Basic Information List
Table Indian Immunologicals Ltd (India) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Indian Immunologicals Ltd (India) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Lohmann Animal Health (US) Basic Information List
Table Lohmann Animal Health (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lohmann Animal Health (US) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Merck Animal Health (US) Basic Information List
Table Merck Animal Health (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Animal Health (US) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Merial Ltd. (US) Basic Information List
Table Merial Ltd. (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merial Ltd. (US) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Protein Sciences Corporation (US) Basic Information List
Table Protein Sciences Corporation (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Protein Sciences Corporation (US) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Virbac SA (France) Basic Information List
Table Virbac SA (France) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Virbac SA (France) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Zoetis Inc. (US) Basic Information List
Table Zoetis Inc. (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zoetis Inc. (US) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Viral-Vectored Vaccines
Figure Manufacturing Process Analysis of Viral-Vectored Vaccines
Figure Viral-Vectored Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Viral-Vectored Vaccines Major Manufacturers in 2015
Table Major Buyers of Viral-Vectored Vaccines
Table Distributors/Traders List
Figure USA Viral-Vectored Vaccines Production and Growth Rate Forecast (2016-2021)
Figure USA Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2016-2021)
Table USA Viral-Vectored Vaccines Production Forecast by Type (2016-2021)
Table USA Viral-Vectored Vaccines Consumption Forecast by Application (2016-2021)